"Leishmaniasis, Visceral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Descriptor ID |
D007898
|
| MeSH Number(s) |
C03.752.300.500.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Visceral".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Visceral".
This graph shows the total number of publications written about "Leishmaniasis, Visceral" by people in this website by year, and whether "Leishmaniasis, Visceral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis, Visceral" by people in Profiles.
-
Morimoto A, Uchida K, Chambers JK, Sato K, Hong J, Sanjoba C, Matsumoto Y, Yamagishi J, Goto Y. Hemophagocytosis induced by Leishmania donovani?infection is beneficial to parasite survival within macrophages. PLoS Negl Trop Dis. 2019 11; 13(11):e0007816.
-
Morimoto A, Omachi S, Osada Y, Chambers JK, Uchida K, Sanjoba C, Matsumoto Y, Goto Y. Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani. PLoS Negl Trop Dis. 2016 Mar; 10(3):e0004505.
-
Lepesheva GI, Hargrove TY, Rachakonda G, Wawrzak Z, Pomel S, Cojean S, Nde PN, Nes WD, Locuson CW, Calcutt MW, Waterman MR, Daniels JS, Loiseau PM, Villalta F. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis. J Infect Dis. 2015 Nov 01; 212(9):1439-48.
-
Jha RK, Sah AK, Shah DK, Sah P. The treatment of visceral leishmaniasis: safety and efficacy. JNMA J Nepal Med Assoc. 2013 Oct-Dec; 52(192):645-51.
-
Melby PC, Tabares A, Restrepo BI, Cardona AE, McGuff HS, Teale JM. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp Parasitol. 2001 Sep; 99(1):17-25.